Dr. Shubhra JaininTarsadia InvestmentsHealthcare Data: The Disruption Opportunity + Why This Time Is DifferentBy: Dr. Shubhra Jain, Jay SantoroMay 12, 20231May 12, 20231
Dr. Shubhra JainEnabling technologies in cell/gene therapyWith FDA approval of the first gene therapy for SMA by Novartis and Bluebird Bio set to launch Zynteglo for transfusion-dependent…Aug 2, 2019Aug 2, 2019
Dr. Shubhra JainPrescribing software — The digital pillWhat are digital therapeutics?Jun 25, 20181Jun 25, 20181